Changchun High & New Technology Industries Group Inc

SHE:000661 China Drug Manufacturers - Specialty & Generic
Market Cap
$5.00 Billion
CN¥36.71 Billion CNY
Market Cap Rank
#3609 Global
#307 in China
Share Price
CN¥90.00
Change (1 day)
-0.20%
52-Week Range
CN¥85.24 - CN¥136.30
All Time High
CN¥1174.87
About

Changchun High-Tech Industry (Group) Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells biopharmaceuticals and traditional Chinese medicines products in China. The company offers genetic engineering, biological vaccines, antibody drugs, chemical drugs, and modern Chinese medicine. It also develops real estate properties. The company was founded in 1993 and is… Read more

Changchun High & New Technology Industries Group Inc (000661) - Net Assets

Latest net assets as of September 2025: CN¥25.94 Billion CNY

Based on the latest financial reports, Changchun High & New Technology Industries Group Inc (000661) has net assets worth CN¥25.94 Billion CNY as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥31.46 Billion) and total liabilities (CN¥5.52 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥25.94 Billion
% of Total Assets 82.45%
Annual Growth Rate 18.27%
5-Year Change 111.81%
10-Year Change 971.89%
Growth Volatility 27.81

Changchun High & New Technology Industries Group Inc - Net Assets Trend (1993–2024)

This chart illustrates how Changchun High & New Technology Industries Group Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Changchun High & New Technology Industries Group Inc (1993–2024)

The table below shows the annual net assets of Changchun High & New Technology Industries Group Inc from 1993 to 2024.

Year Net Assets Change
2024-12-31 CN¥26.10 Billion +4.28%
2023-12-31 CN¥25.03 Billion +20.31%
2022-12-31 CN¥20.81 Billion +20.71%
2021-12-31 CN¥17.24 Billion +39.87%
2020-12-31 CN¥12.32 Billion +39.92%
2019-12-31 CN¥8.81 Billion +39.23%
2018-12-31 CN¥6.33 Billion +21.65%
2017-12-31 CN¥5.20 Billion +16.85%
2016-12-31 CN¥4.45 Billion +82.76%
2015-12-31 CN¥2.44 Billion +19.10%
2014-12-31 CN¥2.04 Billion +20.02%
2013-12-31 CN¥1.70 Billion +30.66%
2012-12-31 CN¥1.30 Billion +37.80%
2011-12-31 CN¥946.20 Million +17.70%
2010-12-31 CN¥803.92 Million +16.35%
2009-12-31 CN¥690.94 Million +20.91%
2008-12-31 CN¥571.43 Million +15.11%
2007-12-31 CN¥496.42 Million +2.72%
2006-12-31 CN¥483.29 Million +15.58%
2005-12-31 CN¥418.13 Million +0.39%
2004-12-31 CN¥416.50 Million -6.72%
2003-12-31 CN¥446.52 Million -23.04%
2002-12-31 CN¥580.18 Million +0.28%
2001-12-31 CN¥578.58 Million -4.50%
2000-12-31 CN¥605.86 Million -23.14%
1999-12-31 CN¥788.27 Million -2.88%
1998-12-31 CN¥811.61 Million +79.95%
1997-12-31 CN¥451.02 Million +27.44%
1996-12-31 CN¥353.90 Million +106.32%
1995-12-31 CN¥171.53 Million +20.48%
1994-12-31 CN¥142.38 Million -0.83%
1993-12-31 CN¥143.57 Million --

Equity Component Analysis

This analysis shows how different components contribute to Changchun High & New Technology Industries Group Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 1748336198500.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥17.48 Billion 76.02%
Common Stock CN¥407.98 Million 1.77%
Other Components CN¥5.11 Billion 22.21%
Total Equity CN¥23.00 Billion 100.00%

Changchun High & New Technology Industries Group Inc Competitors by Market Cap

The table below lists competitors of Changchun High & New Technology Industries Group Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Changchun High & New Technology Industries Group Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 22,074,934,790 to 22,999,514,866, a change of 924,580,076 (4.2%).
  • Net income of 2,583,058,417 contributed positively to equity growth.
  • Dividend payments of 1,838,685,300 reduced retained earnings.
  • Share repurchases of 657,492,035 reduced equity.
  • Other comprehensive income decreased equity by 2,066,729,310.
  • Other factors increased equity by 2,904,428,304.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥2.58 Billion +11.23%
Dividends Paid CN¥1.84 Billion -7.99%
Share Repurchases CN¥657.49 Million -2.86%
Other Comprehensive Income CN¥-2.07 Billion -8.99%
Other Changes CN¥2.90 Billion +12.63%
Total Change CN¥- 4.19%

Book Value vs Market Value Analysis

This analysis compares Changchun High & New Technology Industries Group Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.57x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 159.78x to 1.57x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1995-12-31 CN¥0.56 CN¥90.00 x
1996-12-31 CN¥1.16 CN¥90.00 x
1997-12-31 CN¥1.50 CN¥90.00 x
1998-12-31 CN¥2.35 CN¥90.00 x
1999-12-31 CN¥2.27 CN¥90.00 x
2000-12-31 CN¥1.58 CN¥90.00 x
2001-12-31 CN¥1.50 CN¥90.00 x
2002-12-31 CN¥1.53 CN¥90.00 x
2003-12-31 CN¥1.15 CN¥90.00 x
2004-12-31 CN¥1.16 CN¥90.00 x
2005-12-31 CN¥0.99 CN¥90.00 x
2006-12-31 CN¥1.05 CN¥90.00 x
2007-12-31 CN¥1.09 CN¥90.00 x
2008-12-31 CN¥1.18 CN¥90.00 x
2009-12-31 CN¥1.45 CN¥90.00 x
2010-12-31 CN¥1.74 CN¥90.00 x
2011-12-31 CN¥2.08 CN¥90.00 x
2012-12-31 CN¥3.08 CN¥90.00 x
2013-12-31 CN¥3.95 CN¥90.00 x
2014-12-31 CN¥4.84 CN¥90.00 x
2015-12-31 CN¥6.77 CN¥90.00 x
2016-12-31 CN¥11.46 CN¥90.00 x
2017-12-31 CN¥13.00 CN¥90.00 x
2018-12-31 CN¥15.57 CN¥90.00 x
2019-12-31 CN¥23.39 CN¥90.00 x
2020-12-31 CN¥26.77 CN¥90.00 x
2021-12-31 CN¥35.57 CN¥90.00 x
2022-12-31 CN¥44.29 CN¥90.00 x
2023-12-31 CN¥53.87 CN¥90.00 x
2024-12-31 CN¥57.16 CN¥90.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Changchun High & New Technology Industries Group Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 11.23%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 19.18%
  • • Asset Turnover: 0.43x
  • • Equity Multiplier: 1.35x
  • Recent ROE (11.23%) is below the historical average (11.58%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1995 15.90% 19.89% 0.26x 3.03x CN¥10.02 Million
1996 15.99% 39.69% 0.19x 2.10x CN¥21.02 Million
1997 11.10% 38.44% 0.15x 1.94x CN¥4.97 Million
1998 10.08% 27.49% 0.19x 1.94x CN¥573.74K
1999 2.03% 4.56% 0.23x 1.97x CN¥-54.57 Million
2000 3.52% 5.36% 0.26x 2.48x CN¥-30.95 Million
2001 0.96% 1.07% 0.32x 2.79x CN¥-40.94 Million
2002 0.46% 0.46% 0.37x 2.69x CN¥-43.91 Million
2003 -31.17% -25.50% 0.27x 4.47x CN¥-142.87 Million
2004 2.06% 1.96% 0.26x 4.00x CN¥-27.66 Million
2005 -19.69% -12.09% 0.34x 4.73x CN¥-88.76 Million
2006 1.42% 0.78% 0.40x 4.58x CN¥-27.26 Million
2007 2.29% 1.14% 0.44x 4.61x CN¥-25.30 Million
2008 5.54% 2.50% 0.52x 4.27x CN¥-16.18 Million
2009 16.80% 7.15% 0.66x 3.56x CN¥29.60 Million
2010 16.56% 7.42% 0.66x 3.37x CN¥34.26 Million
2011 17.40% 8.81% 0.60x 3.27x CN¥46.60 Million
2012 32.26% 17.02% 0.76x 2.49x CN¥206.87 Million
2013 23.80% 13.86% 0.73x 2.35x CN¥164.61 Million
2014 21.79% 14.06% 0.72x 2.16x CN¥172.15 Million
2015 21.63% 16.01% 0.63x 2.15x CN¥206.69 Million
2016 12.43% 16.73% 0.47x 1.59x CN¥94.87 Million
2017 14.96% 16.14% 0.56x 1.66x CN¥219.36 Million
2018 19.01% 18.73% 0.57x 1.78x CN¥476.99 Million
2019 21.96% 24.07% 0.58x 1.57x CN¥966.57 Million
2020 27.87% 35.52% 0.51x 1.54x CN¥1.95 Billion
2021 25.78% 34.96% 0.48x 1.54x CN¥2.30 Billion
2022 22.94% 32.79% 0.49x 1.44x CN¥2.34 Billion
2023 20.53% 31.12% 0.47x 1.39x CN¥2.32 Billion
2024 11.23% 19.18% 0.43x 1.35x CN¥283.11 Million

Industry Comparison

This section compares Changchun High & New Technology Industries Group Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $2,123,990,643
  • Average return on equity (ROE) among peers: -0.22%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Changchun High & New Technology Industries Group Inc (000661) CN¥25.94 Billion 15.90% 0.21x $3.47 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078) $6.47 Billion 9.88% 3.77x $616.08 Million
Anhui Fengyuan Pharmaceutical Co Ltd (000153) $1.18 Billion 2.74% 0.95x $320.56 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423) $10.33 Billion 15.07% 0.27x $3.03 Billion
Wedge Industrial Co Ltd (000534) $298.72 Million 1.96% 0.38x $1.77 Billion
Yunnan Baiyao Group Co Ltd (000538) $35.11 Million 18.13% 0.80x $5.62 Billion
Hainan Haiyao Co Ltd (000566) $353.98 Million -9.58% 0.80x $702.18 Million
Tus Pharmaceutical Group Co Ltd (000590) $269.51 Million -61.02% 1.05x $317.08 Million
Northeast Pharmaceutical Group Co Ltd (000597) $927.49 Million 2.65% 1.38x $425.60 Million
Jilin Aodong Pharmaceutical Group Co Ltd (000623) $1.11 Billion 7.32% 0.29x $2.05 Billion
Renhe Pharmacy Co Ltd (000650) $261.49 Million 10.60% 0.82x $777.45 Million